Clinical Trial Update: PreAsthmaControl (PAC) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial (PreAsthmaControl, PAC) sponsored by AstraZeneca in asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 4 | Status: COMPLETED